Novametrix in merger talks for $8 a share:
This article was originally published in Clinica
Novametrix Medical Systems says it is in negotiations with a potential acquirer for around $8 a share. Wallingford, Connecticut-based Novametrix, which makes cardiopulmonary monitors and sensors, did not identify the company and will not comment further until a deal is announced or discussions are abandoned. The company had turnover of $24.8 million in the six months to October 28.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.